SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001213900-24-036819
Filing Date
2024-04-29
Accepted
2024-04-29 07:15:52
Documents
19

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO FORM S-1 ea0204833-s1a2_tffpharma.htm   iXBRL S-1/A 390673
2 OPINION OF GREENBERG TRAURIG, LLP ea020483301ex5-1_tffpharma.htm EX-5.1 11843
3 CONSENT OF MARCUM, LLP ea020483301ex23-1_tffpharma.htm EX-23.1 2212
4 FILING FEE TABLE ea020483301ex-fee_tffpha.htm EX-FILING FEES 59145
5 GRAPHIC image_001.jpg GRAPHIC 3067
  Complete submission text file 0001213900-24-036819.txt   628523

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE tffp-20231231.xsd EX-101.SCH 3255
7 XBRL DEFINITION FILE tffp-20231231_def.xml EX-101.DEF 6179
8 XBRL LABEL FILE tffp-20231231_lab.xml EX-101.LAB 9513
9 XBRL PRESENTATION FILE tffp-20231231_pre.xml EX-101.PRE 6049
22 EXTRACTED XBRL INSTANCE DOCUMENT ea0204833-s1a2_tffpharma_htm.xml XML 1576
Mailing Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746
Business Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746 737-802-1973
TFF Pharmaceuticals, Inc. (Filer) CIK: 0001733413 (see all company filings)

IRS No.: 824344737 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-278546 | Film No.: 24886580
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)